Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Tobramycin 300mg/4ml nebuliser liquid ampoules |
BNF code | 0501040U0AAAKAK |
Virtual Therapeutic Moiety | Tobramycin |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 1 Feb 2010 |
Previous name | Tobramycin 75mg/ml nebuliser liquid 4ml ampoules |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 4.000 |
Unit dose form units | ml |
Unit dose unit of measure | ampoule |
Virtual Product Ingredient | |
---|---|
Ingredient | Tobramycin |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 75.000 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | solutionnebuliser.inhalation |
Dose Form | |
Formulation | Nebuliser liquid |
Drug Route | |
Route | Inhalation |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Bramitob 300mg/4ml nebuliser solution 4ml ampoules (Chiesi Ltd) | |
Virtual Medicinal Product Packs | |
Tobramycin 300mg/4ml nebuliser liquid ampoules 56 ampoule |
dm+d data retrieved from TRUD: release NHSBSA_1.2.0_20250113000001, imported on 14th January 2025 at 04:06:47.